Treatment Persistence Between Long-Acting Injectable Versus Orally Administered Aripiprazole Among Patients with Schizophrenia in a Real-World Clinical Setting in Japan

INTRODUCTION: Persistence with antipsychotic treatment is critical in managing patients with schizophrenia. To evaluate whether aripiprazole long-acting injection (aripiprazole once-monthly, AOM) can contribute to longer treatment persistence compared with daily orally administered aripiprazole (OA)...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwata, Nakao, Inagaki, Ataru, Sano, Hiromi, Niidome, Kazunari, Kojima, Yoshitsugu, Yamada, Sakiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314731/
https://www.ncbi.nlm.nih.gov/pubmed/32500455
http://dx.doi.org/10.1007/s12325-020-01396-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7314731/
https://www.ncbi.nlm.nih.gov/pubmed/32500455
http://dx.doi.org/10.1007/s12325-020-01396-w

Ejemplares similares